{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:14:03Z","timestamp":1778163243385,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.transproceed.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:40:25Z","timestamp":1776771625000},"page":"730-738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rabbit Antithymocyte Globulin vs Basiliximab Induction in ABO-Incompatible Kidney Transplantation: A Single-Center Retrospective Cohort Study"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-7318","authenticated-orcid":false,"given":"Eunju","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Yoon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung-Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Seob","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Cheol","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Hyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Kye","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.transproceed.2026.04.007_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2012.07.003","article-title":"ABO-incompatible kidney transplantation","volume":"27","author":"Takahashi","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"issue":"7","key":"10.1016\/j.transproceed.2026.04.007_bib0002","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/TXD.0000000000000695","article-title":"The UK national registry of ABO and HLA antibody incompatible renal transplantation: pretransplant factors associated with outcome in 879 transplants","volume":"3","author":"Pankhurst","year":"2017","journal-title":"Transplant Direct"},{"key":"10.1016\/j.transproceed.2026.04.007_bib0003","first-page":"970421","article-title":"ABO incompatible kidney transplantation-current status and uncertainties","volume":"2011","author":"Shin","year":"2011","journal-title":"J Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2026.04.007_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051320","article-title":"Outcome comparison between low-dose rabbit anti-thymocyte globulin and basiliximab in low-risk living donor kidney transplantation","volume":"9","author":"Kim","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.transproceed.2026.04.007_bib0005","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1159\/000351643","article-title":"Thymoglobulin and its use in renal transplantation: a review","volume":"37","author":"Thiyagarajan","year":"2013","journal-title":"Am J Nephrol"},{"issue":"26","key":"10.1016\/j.transproceed.2026.04.007_bib0006","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.transproceed.2026.04.007_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104408","article-title":"Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study","volume":"9","author":"Grafals","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.transproceed.2026.04.007_bib0008","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.tp.0000234905.56926.7f","article-title":"Induction immunosuppression","volume":"82","author":"Kirk","year":"2006","journal-title":"Transplantation"},{"issue":"19","key":"10.1016\/j.transproceed.2026.04.007_bib0009","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.transproceed.2026.04.007_bib0010","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.intimp.2011.07.012","article-title":"Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin","volume":"11","author":"Lib\u00f3rio","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"10.1016\/j.transproceed.2026.04.007_bib0011","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1681\/ASN.2016070768","article-title":"Comparing outcomes between antibody induction therapies in kidney transplantation","volume":"28","author":"Koyawala","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.transproceed.2026.04.007_bib0012","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4285\/jkstn.2019.33.4.118","article-title":"Comparison of clinical outcomes of deceased donor kidney transplantations, with a focus on three induction therapies","volume":"33","author":"Jeong","year":"2019","journal-title":"Korean J Transplant"},{"issue":"1","key":"10.1016\/j.transproceed.2026.04.007_bib0013","doi-asserted-by":"crossref","first-page":"138","DOI":"10.23876\/j.krcp.21.159","article-title":"The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study","volume":"42","author":"Hong","year":"2023","journal-title":"Kidney Res Clin Pract"},{"issue":"2","key":"10.1016\/j.transproceed.2026.04.007_bib0014","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/TP.0000000000000312","article-title":"Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers","volume":"99","author":"Opelz","year":"2015","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.transproceed.2026.04.007_bib0015","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2215\/CJN.00770112","article-title":"Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients","volume":"7","author":"Sharif","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.transproceed.2026.04.007_bib0016","article-title":"Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients","volume":"1","author":"Hill","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.transproceed.2026.04.007_bib0017","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1586\/14787210.2014.917046","article-title":"Risk of serious opportunistic infections after solid organ transplantation: interleukin-2 receptor antagonists versus polyclonal antibodies. A meta-analysis","volume":"12","author":"Kalil","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"12","key":"10.1016\/j.transproceed.2026.04.007_bib0018","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/tri.12979","article-title":"Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study","volume":"30","author":"Ko","year":"2017","journal-title":"Transpl Int"},{"issue":"10","key":"10.1016\/j.transproceed.2026.04.007_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13681","article-title":"Anti-IL-2R blockers comparing with polyclonal antibodies: higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantation","volume":"33","author":"Del Bello","year":"2019","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2026.04.007_bib0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.23876\/j.krcp.21.310","article-title":"Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry","volume":"41","author":"Lee","year":"2022","journal-title":"Kidney Res Clin Pract"},{"issue":"8","key":"10.1016\/j.transproceed.2026.04.007_bib0021","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.00540118","article-title":"ABO-incompatible kidney transplant outcomes: a meta-analysis","volume":"13","author":"de Weerd","year":"2018","journal-title":"CJASN"},{"issue":"12","key":"10.1016\/j.transproceed.2026.04.007_bib0022","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1111\/tri.14145","article-title":"ABO-incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity-matched analysis","volume":"34","author":"de Weerd","year":"2021","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.transproceed.2026.04.007_bib0023","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39353-6","article-title":"Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients","volume":"13","author":"Shim","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.transproceed.2026.04.007_bib0024","doi-asserted-by":"crossref","first-page":"126","DOI":"10.21037\/tau.2019.03.05","article-title":"Current protocols and outcomes of ABO-incompatible kidney transplantation based on a single-center experience","volume":"8","author":"Okumi","year":"2019","journal-title":"Transl Androl Urol"},{"issue":"7","key":"10.1016\/j.transproceed.2026.04.007_bib0025","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.transproceed.2004.07.051","article-title":"Efficacy of basiliximab induction therapy in ABO-incompatible kidney transplantation: a rapid steroid withdrawal protocol","volume":"36","author":"Ando","year":"2004","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.transproceed.2026.04.007_bib0026","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajt.13884","article-title":"Induction therapy for kidney transplant recipients: do we still need anti-IL2 receptor monoclonal antibodies?","volume":"17","author":"Hellemans","year":"2017","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.transproceed.2026.04.007_bib0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1319-2442.124459","article-title":"Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: long-term outcome","volume":"25","author":"Kesiraju","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"1","key":"10.1016\/j.transproceed.2026.04.007_bib0028","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.transproceed.2011.12.063","article-title":"Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study","volume":"44","author":"Kim","year":"2012","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.transproceed.2026.04.007_bib0029","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13257","article-title":"Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti-thymocyte globulin vs basiliximab","volume":"22","author":"Pham","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"10.1016\/j.transproceed.2026.04.007_bib0030","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1111\/ajt.15342","article-title":"Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation","volume":"19","author":"Alloway","year":"2019","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2026.04.007_bib0031","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/SLA.0000000000000496","article-title":"Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation","volume":"259","author":"Pilch","year":"2014","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.transproceed.2026.04.007_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165233","article-title":"A comparison of two types of rabbit antithymocyte globulin induction therapy in immunological high-risk kidney recipients: a prospective randomized control study","volume":"11","author":"Burkhalter","year":"2016","journal-title":"PLoS One"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526001879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526001879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:42:22Z","timestamp":1778161342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526001879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0041134526001879"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.04.007","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabbit Antithymocyte Globulin vs Basiliximab Induction in ABO-Incompatible Kidney Transplantation: A Single-Center Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}